Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reslizumab and Eosinophilic Asthma: One Step Closer to Phenotype-directed Therapy?

1 Nov 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asthma and respiratory diseases
Share to Eosinophilic Esophagitis
Share to Respiratory and Cough-Related Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 22086982
DOI: 10.1164/rccm.201108-1565ed

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reslizumab and Eosinophilic Asthma: One Step Closer to Phenotype-directed Therapy?PMID 22086982Read ↗

Eosinophilic phenotypes of airway disease.Semantic proximity Read ↗

Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy.Semantic proximity Read ↗

What is an “eosinophilic phenotype” of asthma?Semantic proximity Read ↗

Evidence for phenotype-driven treatment in asthmatic patients.Semantic proximity Read ↗

Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotypeSemantic proximity Read ↗

The immunology of asthma: Asthma phenotypes and their implications for personalized treatment.Semantic proximity Read ↗

Reslizumab in the treatment of severe eosinophilic asthma: an update.Semantic proximity Read ↗

Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.Semantic proximity Read ↗

Choice of biologics in asthma endotypes.Semantic proximity Read ↗

Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.Semantic proximity Read ↗

Moving towards precision care for childhood asthma.Semantic proximity Read ↗

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.